Page 114 - Clinical Practice Guideline
P. 114

บันทึก

              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................

              ..................................................................................................................................................
              ..................................................................................................................................................




             106 คู຋มือ฽นวทาง฼วชฏิบัติ༛(Clinical༛Practice༛Guideline)༛การดู฽ลผูຌปຆวยระยะกลาง༛(Intermediate༛Care)༛
                  ดຌานการ฽พทยຏ฽ผนเทย฽ละการ฽พทยຏทาง฼ลือก
   109   110   111   112   113   114